Developed, facilitated and described findings of an expert panel of cardiologists on assessing opportunities for emerging therapeutic agents in several cardiac diseases.
Performed cost-effectiveness and cost-benefit analyses of a new medical device to evaluate the disease-related financial burden from the perspectives of provides and payers.
Developed, facilitated, and helped publish the proceedings of a Symposium of cardiology thought leaders dealing with Current and Future therapy for Treating Coronary Artery Disease and Heart Failure.
Designed a strategy to increase product line penetration in the managed care sector.
Advised a pharmaceutical company, helping to design a plan to increase its market share in the price- sensitive marketplace
Determined the market sizes and opportunities for products and services based on clinical incidence, competitive products and therapies, and physician and patient preferences.
Conducted competitive analyses to determine strengths and weaknesses of specific products, product lines, operating procedures, and organizational structure.
Developed and conducted sales-training programs to educate representatives on the impact of emerging public and private policies and corporate product-support programs to capitalize on the new environment.
Developed and lectured at a workshop, Drug Utilization in Transition, sponsored by a pharmaceutical company and offered to a small group of professionals concerned with the management of prescription drug benefits and services.
Developed a manual describing techniques of effective communication for a client to offer as an educational service to its customers.
